Rohit Sood

Amplity, a full-service partner for outsourcing flexible medical and commercial services, delivers cutting-edge, expert-led teams and solutions at every stage of the drug development lifecycle for better patient outcomes. Our range of services drive biopharma innovation and sales in critical areas: Amplity Medical - Outsourcing global clinical + medical engagement for accelerated drug approval + acceptance Amplity Commercial - Flexible, scalable commercial teams for rapid product launch & lifecycle management Amplity Intel - Home of AnswerY™, our AI-driven, HIPAA-compliant platform of doctors’ post-visit summaries of patient visits that drives next-best actions Amplity Learn - Continuous training growth for teams and individuals led by pharma industry experts Amplity MedComms - Impactful medical communications & omnichannel pharma marketing to set brands apart We are trusted by top pharma + biotech companies worldwide for 40+ years. If you need help + honest advice to reach your medical and commercialization goals, we’d love to help you succeed. At Amplity, we are your allies in excellence. And we do it quicker, better, and nicer than anyone else. Get the Amplity difference.

Sorcero is on a mission to improve patient outcomes by empowering life sciences experts. The Sorcero Intelligence Platform enables teams at the top global life sciences enterprises to explore vast libraries of unstructured medically relevant content, illuminating the most meaningful analytics and medical insights.

Spending decades as SaaS operators, we faced first hand the limitations of traditional data architectures. Expensive, bulky, and often failing to answer simple questions, these tools ultimately created more stress than insights… and that’s why we built Discern. Delivered as out of the box business intelligence, Discern breaks down operational siloes, answers key questions, and identifies critical risks. Through partnership with top PE firms, Discern has incorporated best practice dashboards and KPI definitions directly in the platform, making it easy for you to align your business with operational excellence. Because we’ve standardized system integrations, KPI calculations, and GTM dashboards, Discern has the unique advantage of delivering real insights in a matter of weeks. Are you ready to say goodbye to the BI BS?

Amplity, a full-service partner for outsourcing flexible medical and commercial services, delivers cutting-edge, expert-led teams and solutions at every stage of the drug development lifecycle for better patient outcomes. Our range of services drive biopharma innovation and sales in critical areas: Amplity Medical - Outsourcing global clinical + medical engagement for accelerated drug approval + acceptance Amplity Commercial - Flexible, scalable commercial teams for rapid product launch & lifecycle management Amplity Intel - Home of AnswerY™, our AI-driven, HIPAA-compliant platform of doctors’ post-visit summaries of patient visits that drives next-best actions Amplity Learn - Continuous training growth for teams and individuals led by pharma industry experts Amplity MedComms - Impactful medical communications & omnichannel pharma marketing to set brands apart We are trusted by top pharma + biotech companies worldwide for 40+ years. If you need help + honest advice to reach your medical and commercialization goals, we’d love to help you succeed. At Amplity, we are your allies in excellence. And we do it quicker, better, and nicer than anyone else. Get the Amplity difference.

We partner with life science companies—from emerging biotechs to established manufacturers, service providers, and software firms—to bridge the gap between groundbreaking science and market leadership. With deep expertise across the commercial lifecycle, we help organizations navigate their most critical growth inflection points: preparing for launch, entering new markets, scaling commercial operations, and transforming how they engage customers in an increasingly digital world. What We Do: We work alongside leadership teams to build commercial capabilities that drive sustainable growth. Our focus areas include go-to-market strategy development, launch planning and execution, commercial readiness assessments, operational diligence, digital transformation initiatives, and executive coaching for commercial leaders. Whether you are preparing for a product launch, expanding into new therapeutic areas or geographies, modernizing your commercial model, or building organizational capabilities for scale, we bring both strategic clarity and hands-on execution support. Our Approach: Every life science company faces unique challenges. We take time to understand your science, your market dynamics, and your organizational realities before recommending solutions. The result is practical, actionable strategies that your teams can execute with confidence. We have experienced firsthand that commercial success in life sciences requires more than a great product—it demands clear strategy, cross-functional alignment, market insight, and leaders equipped to navigate complexity. Lets Connect: If you are leading commercial strategy, preparing for a launch, or building capabilities for your next phase of growth, wed welcome a conversation about how we can work together.

Advent is a leading global private equity investor committed to working in partnership with management teams, entrepreneurs, and founders to help transform businesses. Since our founding in 1984, we have developed specialist market expertise across our five core sectors: business & financial services, consumer, healthcare, industrial, and technology. As one of the largest privately-owned partnerships, our 600+ colleagues across five continents leverage the full ecosystem of Advent’s global resources to support and guide our portfolio companies as they seek to achieve their strategic goals. To learn more, visit adventinternational.com.

Sorcero is on a mission to improve patient outcomes by empowering life sciences experts. The Sorcero Intelligence Platform enables teams at the top global life sciences enterprises to explore vast libraries of unstructured medically relevant content, illuminating the most meaningful analytics and medical insights.

FFL was formed in 1997 to invest in middle-market companies where the firm’s substantial strategic and operating expertise can help management accelerate growth and build better businesses. Our capital comes largely from U.S. and international institutions: public and private pension funds, endowments, foundations, and financial institutions. FFL has invested prudently for over 20 years, partnering with strong management teams and other investors to establish a leading track record in middle-market private equity investing. The firm generally commits $50-200 million to individual transactions and has the ability to make larger commitments in selected circumstances.